Catalyst Wire Dossier Catalyst Wire Dossier

TJ0113

· Hangzhou PhecdaMed Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TJ0113, covering 2025-11-17 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose Study(SAD),Multiple Ascending Dose Study(MAD) , High-fat Diet Study (FE) of TJ0113 Capsules in Healthy Subjects [Phase 1]

See pricing